Literature DB >> 32815641

Frequency & factors associated with apparent resistant hypertension among Ghanaians in a multicenter study.

Nana Kwame Ayisi-Boateng1,2, Aliyu Mohammed3, Douglas Aninng Opoku3, Fred Stephen Sarfo1,4.   

Abstract

Apparent resistant hypertension (ARH) is rife among people living with hypertension and is associated with significant morbidity and mortality. There is however paucity of data from sub-Saharan Africa on the burden of ARH. We sought to report on the frequency and factors associated with ARH among a cohort of Ghanaians with hypertension. A cross-sectional study involving 2912 participants with hypertension enrolled at five health facilities in Ghana. ARH was defined as either office BP ≥ 140/90 mm Hg on 3 or more antihypertensive medications or on 4 or more antihypertensive medications regardless of BP. Factors associated with ARH were evaluated in a multivariate logistic regression model. We found 550 out of 2,912 (18.9%) of study participants had ARH. Out of these 550 subjects, 511 (92.9%) were on 3 or more antihypertensive medications with BP ≥ 140/90 mm Hg and 39 (7.1%) were on 4 or more antihypertensive medications with BP ≥ 140/90 mm Hg. The prevalence of ARH was 15.5% among elderly aged 75 + years (n = 341), 20.7% among 65-74 years (n = 588), and 18.9% among those ≤ 64 years (n = 1983). The adjusted odds ratio (95% CI) of factors independently associated with ARH was duration of hypertension, 1.05 (1.03-1.06) for each year rise; eGFR < 60 mL/min, 1.73 (1.33-2.25); and diabetes mellitus, 0.59 (0.46-0.76). Attaining secondary level education and residence in a peri-urban setting were significantly associated with ARH though not in a dose-dependent manner. ARH is rife among Ghanaians and may negatively impact on cardiovascular outcomes in the long term.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  Ghanaians; apparent; hypertension; prevalence; resistant

Mesh:

Substances:

Year:  2020        PMID: 32815641      PMCID: PMC8029809          DOI: 10.1111/jch.13974

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  43 in total

1.  Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries.

Authors:  Clara K Chow; Koon K Teo; Sumathy Rangarajan; Shofiqul Islam; Rajeev Gupta; Alvaro Avezum; Ahmad Bahonar; Jephat Chifamba; Gilles Dagenais; Rafael Diaz; Khawar Kazmi; Fernando Lanas; Li Wei; Patricio Lopez-Jaramillo; Lu Fanghong; Noor Hassim Ismail; Thandi Puoane; Annika Rosengren; Andrzej Szuba; Ahmet Temizhan; Andy Wielgosz; Rita Yusuf; Afzalhussein Yusufali; Martin McKee; Lisheng Liu; Prem Mony; Salim Yusuf
Journal:  JAMA       Date:  2013-09-04       Impact factor: 56.272

2.  Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale.

Authors:  M T Kim; M N Hill; L R Bone; D M Levine
Journal:  Prog Cardiovasc Nurs       Date:  2000

Review 3.  Apparent and true resistant hypertension: definition, prevalence and outcomes.

Authors:  E Judd; D A Calhoun
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

Review 4.  Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.

Authors:  Costas Thomopoulos; Gianfranco Parati; Alberto Zanchetti
Journal:  J Hypertens       Date:  2015-02       Impact factor: 4.844

5.  Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension.

Authors:  Tanja Dudenbostel; Lama Ghazi; Mingchun Liu; Peng Li; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2016-08-15       Impact factor: 10.190

6.  Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.

Authors:  Brent M Egan; Yumin Zhao; Jiexiang Li; W Adam Brzezinski; Thomas M Todoran; Robert D Brook; David A Calhoun
Journal:  Hypertension       Date:  2013-08-05       Impact factor: 10.190

7.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

Review 8.  What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?

Authors:  Samir G Mallat
Journal:  Cardiovasc Diabetol       Date:  2012-04-10       Impact factor: 9.951

9.  Dominant modifiable risk factors for stroke in Ghana and Nigeria (SIREN): a case-control study.

Authors:  Mayowa O Owolabi; Fred Sarfo; Rufus Akinyemi; Mulugeta Gebregziabher; Onoja Akpa; Albert Akpalu; Kolawole Wahab; Reginald Obiako; Lukman Owolabi; Bruce Ovbiagele
Journal:  Lancet Glob Health       Date:  2018-02-26       Impact factor: 26.763

10.  Prevalence, awareness, treatment and control of hypertension in a self-selected sub-Saharan African urban population: a cross-sectional study.

Authors:  Anastase Dzudie; André Pascal Kengne; Walinjom F T Muna; Hamadou Ba; Alain Menanga; Charles Kouam Kouam; Joseph Abah; Yves Monkam; Christian Biholong; Pierre Mintom; Félicité Kamdem; Armel Djomou; Jules Ndjebet; Cyrille Wambo; Henry Luma; Kathleen Blackett Ngu; Samuel Kingue
Journal:  BMJ Open       Date:  2012-08-24       Impact factor: 2.692

View more
  6 in total

1.  Apparent resistant hypertension in sub-Saharan Africa: Frequency and associated factors.

Authors:  Elizabeth W Edwards; Sean Battle; Donald J DiPette
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-06       Impact factor: 3.738

2.  Atherosclerotic event risk and risk reduction therapies among Ghanaian hemorrhagic stroke survivors.

Authors:  Fred Stephen Sarfo; Sheila Adamu; Vida Obese; Manolo Agbenorku; Priscilla Abrafi Opare-Addo; Bruce Ovbiagele
Journal:  J Neurol Sci       Date:  2021-03-10       Impact factor: 3.181

Review 3.  Pathophysiologically based antihypertensive pharmacotherapeutics rationality, efficacy and safety in Sub Saharan African Nations - A review.

Authors:  A A L Ajayi; O E Ajayi
Journal:  Int J Cardiol Cardiovasc Risk Prev       Date:  2021-10-28

4.  Frequency & factors associated with apparent resistant hypertension among Ghanaians in a multicenter study.

Authors:  Nana Kwame Ayisi-Boateng; Aliyu Mohammed; Douglas Aninng Opoku; Fred Stephen Sarfo
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-20       Impact factor: 3.738

5.  Apparent Treatment Resistant Hypertension Among Stroke Survivors in Ghana.

Authors:  Fred Stephen Sarfo; Bruce Ovbiagele
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-10-21       Impact factor: 2.136

6.  Factors associated with incidence of stroke and heart failure among people living with HIV in Ghana: Evaluating Vascular Event Risk while on Long-Term Antiretroviral Suppressive Therapy (EVERLAST) Study.

Authors:  Fred Stephen Sarfo; Betty Norman; Lambert Appiah; Bruce Ovbiagele
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-05-03       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.